Clinical outcome of long-term lamivudine treated chronic HBV infected and HIV/HBV coinfected patients

Saved in:
Bibliographic Details
Published inJournal of clinical virology Vol. 33; no. 1; pp. 80 - 82
Main Authors Elefsiniotis, Ioannis S., Paparizos, V., Dourakis, S.P., Mpotsi, C., Pantazis, K.D., Katsambas, N.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.05.2005
Subjects
Adult
Anti-HIV Agents - administration & dosage
Anti-HIV Agents - therapeutic use
Drug Therapy, Combination
Female
Hepatitis B, Chronic - complications
Hepatitis B, Chronic - drug therapy
Hepatitis B, Chronic - physiopathology
Hepatitis B, Chronic - virology
HIV Infections - complications
HIV Infections - drug therapy
HIV Infections - physiopathology
HIV Infections - virology
Humans
Lamivudine - administration & dosage
Lamivudine - therapeutic use
Male
Middle Aged
Retrospective Studies
Reverse Transcriptase Inhibitors - administration & dosage
Reverse Transcriptase Inhibitors - therapeutic use
Time Factors
Treatment Outcome
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Feature-1
ObjectType-Correspondence-3
ISSN:1386-6532
1873-5967
DOI:10.1016/j.jcv.2004.12.002